Trials / Completed
CompletedNCT02825745
Use of Betashot in Children and Adults With Epilepsy
A Feasibility Study of the Use of Betashot, a Medium Chain Triglyceride- Based (MCT) Food for Special Medical Purposes (FSMP) in Children and Adults With Epilepsy.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 77 (actual)
- Sponsor
- Vitaflo International, Ltd · Industry
- Sex
- All
- Age
- 3 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
In brief, this research is a prospective, feasibility study to evaluate the use of Betashot- a medium chain triglyceride- based (MCT) food for special medical purposes (FSMP) in children and adults diagnosed with epilepsy. MCT is a type of dietary fat used in the ketogenic diet.
Detailed description
This study aims to explore the use of Betashot in a group of children and adults with epilepsy who are consuming their normal diets, but limiting intakes of foods high in carbohydrate and sugars. The participants will be required to drink Betashot to enable the following assessment: 1. Tolerance (side effects such as bloating or cramps) 2. Acceptability (flavour, texture, taste) 3. Compliance (how easy it is to use Betashot at the advised quantity, as part of their daily diet)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Betashot | Betashot is a Food for Special Medical Purposes (FSMP). Suitable for use from 3 years of age. |
Timeline
- Start date
- 2016-06-29
- Primary completion
- 2019-05-31
- Completion
- 2019-12-31
- First posted
- 2016-07-07
- Last updated
- 2024-02-16
Locations
2 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02825745. Inclusion in this directory is not an endorsement.